Mark B Lockwood1, Milda R Saunders2, Rachel Nass3, Claire L McGivern4, Patrick N Cunningham3, W James Chon5, Michelle A Josephson3, Yolanda T Becker4, Christopher S Lee6. 1. 1 University of Illinois at Chicago College of Nursing, Department of Biobehavioral Science. 2. 2 University of Chicago Medicine, Hospital Medicine and MacLean Center for Clinical Medical Ethics. 3. 3 University of Chicago Medicine, Department of Medicine. 4. 4 University of Chicago Medicine, Department of Surgery. 5. 5 University of Arkansas for Medical Sciences, Department of Medicine. 6. 6 Oregon Health and Science University, School of Nursing.
Abstract
BACKGROUND: Despite our knowledge of barriers to the early stages of the transplant process, we have limited insight into patient-reported barriers to the prekidney transplant medical evaluation in populations largely at-risk for evaluation failure. METHODS: One-hundred consecutive adults were enrolled at an urban, Midwestern transplant center. Demographic, clinical, and quality of life data were collected prior to patients visit with a transplant surgeon/nephrologist (evaluation begins). Patient-reported barriers to evaluation completion were collected using the Subjective Barriers Questionnaire 90-days after the initial medical evaluation appointment (evaluation ends), our center targeted goal for transplant work-up completion. RESULTS: At 90 days, 40% of participants had not completed the transplant evaluation. Five barrier categories were created from the 85 responses to the Subjective Barriers Questionnaire. Patient-reported barriers included poor communication, physical health, socioeconomics, psychosocial influences, and access to care. In addition, determinants for successful evaluation completion included being of white race, higher income, free of dialysis, a lower comorbid burden, and reporting higher scores on the Kidney Disease Quality of Life subscale role-emotional. CONCLUSION: Poor communication between patients and providers, and among providers, was the most prominent patient-reported barrier identified. Barriers were more prominent in marginalized groups such as ethnic minorities and people with low income. Understanding the prevalence of patient-reported barriers may aid in the development of patient-centered interventions to improve completion rates.
BACKGROUND: Despite our knowledge of barriers to the early stages of the transplant process, we have limited insight into patient-reported barriers to the prekidney transplant medical evaluation in populations largely at-risk for evaluation failure. METHODS: One-hundred consecutive adults were enrolled at an urban, Midwestern transplant center. Demographic, clinical, and quality of life data were collected prior to patients visit with a transplant surgeon/nephrologist (evaluation begins). Patient-reported barriers to evaluation completion were collected using the Subjective Barriers Questionnaire 90-days after the initial medical evaluation appointment (evaluation ends), our center targeted goal for transplant work-up completion. RESULTS: At 90 days, 40% of participants had not completed the transplant evaluation. Five barrier categories were created from the 85 responses to the Subjective Barriers Questionnaire. Patient-reported barriers included poor communication, physical health, socioeconomics, psychosocial influences, and access to care. In addition, determinants for successful evaluation completion included being of white race, higher income, free of dialysis, a lower comorbid burden, and reporting higher scores on the Kidney Disease Quality of Life subscale role-emotional. CONCLUSION: Poor communication between patients and providers, and among providers, was the most prominent patient-reported barrier identified. Barriers were more prominent in marginalized groups such as ethnic minorities and people with low income. Understanding the prevalence of patient-reported barriers may aid in the development of patient-centered interventions to improve completion rates.
Authors: Laura J McPherson; Vaughn Barry; Jane Yackley; Jennifer C Gander; Stephen O Pastan; Laura C Plantinga; Sudeshna Paul; Rachel E Patzer Journal: Clin J Am Soc Nephrol Date: 2020-03-24 Impact factor: 8.237
Authors: Amy D Waterman; John D Peipert; Yujie Cui; Jennifer L Beaumont; Andrea Paiva; Amanda F Lipsey; Crystal S Anderson; Mark L Robbins Journal: Am J Transplant Date: 2020-09-15 Impact factor: 8.086
Authors: Reem E Hamoda; Jennifer C Gander; Laura J McPherson; Kimberly J Arriola; Loren Cobb; Stephen O Pastan; Laura Plantinga; Teri Browne; Erica Hartmann; Laura Mulloy; Carlos Zayas; Jenna Krisher; Rachel E Patzer Journal: BMC Nephrol Date: 2018-01-15 Impact factor: 2.388
Authors: Teri Browne; Laura McPherson; Samantha Retzloff; Amandha Darius; Adam S Wilk; Alexandra Cruz; Shannon Wright; Stephen O Pastan; Jennifer C Gander; Alexander A Berlin; Rachel E Patzer Journal: Kidney Med Date: 2021-07-07
Authors: Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy Journal: Int J Equity Health Date: 2022-02-12
Authors: Edward Zimbudzi; Clement Lo; Sanjeeva Ranasinha; Gregory Fulcher; Martin Gallagher; Stephen Jan; Peter G Kerr; Helena J Teede; Kevan R Polkinghorne; Grant Russell; Rowan G Walker; Sophia Zoungas Journal: Health Qual Life Outcomes Date: 2018-11-19 Impact factor: 3.186
Authors: Daniel J Watford; Xingxing S Cheng; Jialin Han; Margaret R Stedman; Glenn M Chertow; Jane C Tan Journal: Clin Transplant Date: 2020-12-14 Impact factor: 2.863